rFVIIa
Baxter’s haemophilia drug performs
March 17, 2015Sales and Marketing BAX 817, VIIa, baxter, haemophilia, rFVIIa
Baxter International has reported positive Phase III clinical trial results for its investigational haemophilia drug BAX 817. The recombinant factor VIIa …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
